These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38707730)

  • 1. Oxaliplatin-induced Acute Neurotoxicity Recovers Between Repeat Infusion Cycles: An Axonal Excitability Repeated Multiple Measurements Study.
    Kokotis P; Papantoniou M; Carr RW; Schmelz M; Siakavella D; Skafida E; Papadimitriou C
    Cancer Diagn Progn; 2024; 4(3):320-325. PubMed ID: 38707730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
    Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve excitability assessment in chemotherapy-induced neurotoxicity.
    Park SB; Lin CS; Kiernan MC
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22565594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute changes in nerve excitability following oxaliplatin treatment in mice.
    Makker PGS; White D; Lees JG; Parmar J; Goldstein D; Park SB; Howells J; Moalem-Taylor G
    J Neurophysiol; 2020 Jul; 124(1):232-244. PubMed ID: 32519566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.
    Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC
    J Clin Oncol; 2009 Mar; 27(8):1243-9. PubMed ID: 19164207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy.
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
    Exp Neurol; 2011 Jan; 227(1):120-7. PubMed ID: 20965170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation.
    Heide R; Bostock H; Ventzel L; Grafe P; Bergmans J; Fuglsang-Frederiksen A; Finnerup NB; Tankisi H
    Clin Neurophysiol; 2018 Mar; 129(3):694-706. PubMed ID: 29233604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin and axonal Na+ channel function in vivo.
    Krishnan AV; Goldstein D; Friedlander M; Kiernan MC
    Clin Cancer Res; 2006 Aug; 12(15):4481-4. PubMed ID: 16899592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity.
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
    PLoS One; 2011 Apr; 6(4):e18469. PubMed ID: 21494615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
    Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
    Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early discrimination of sensorimotor Guillain-Barré syndrome into demyelinating or axonal subtype by automated nerve excitability testing.
    Pyun SY; Kang MR; Lee JY; Kuk KJ; Oh SI; Bae JS
    J Peripher Nerv Syst; 2017 Jun; 22(2):85-91. PubMed ID: 28397393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
    Hill A; Bergin P; Hanning F; Thompson P; Findlay M; Damianovich D; McKeage MJ
    BMC Cancer; 2010 Aug; 10():451. PubMed ID: 20731872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological investigation of motor axonal excitability in a mouse model of nerve constriction injury.
    Makker PGS; Keating BA; Lees JG; Burke D; Howells J; Moalem-Taylor G
    J Peripher Nerv Syst; 2021 Mar; 26(1):99-112. PubMed ID: 33432642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold aggravates abnormal excitability of motor axons in oxaliplatin-treated patients.
    Bennedsgaard K; Ventzel L; Grafe P; Tigerholm J; Themistocleous AC; Bennett DL; Tankisi H; Finnerup NB
    Muscle Nerve; 2020 Jun; 61(6):796-800. PubMed ID: 32133655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures.
    Gamelin E; Gamelin L; Bossi L; Quasthoff S
    Semin Oncol; 2002 Oct; 29(5 Suppl 15):21-33. PubMed ID: 12422305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study.
    Themistocleous AC; Kristensen AG; Sola R; Gylfadottir SS; Bennedsgaard K; Itani M; Krøigård T; Ventzel L; Sindrup SH; Jensen TS; Bostock H; Serra J; Finnerup NB; Tankisi H; Bennett DLH
    Ann Neurol; 2022 Apr; 91(4):506-520. PubMed ID: 35150149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Essential Tremor Alter the Axonal Excitability Properties of Lower Motor Neurons?
    Kim Y; Kim YE; Lee JY; Ma HI; Shim SK; Yoon SM; Bae JS
    J Clin Neurophysiol; 2022 Sep; 39(6):492-496. PubMed ID: 33369992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased variability of axonal excitability in amyotrophic lateral sclerosis.
    Shibuta Y; Shimatani Y; Nodera H; Izumi Y; Kaji R
    Clin Neurophysiol; 2013 Oct; 124(10):2046-53. PubMed ID: 23726502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin-induced neurotoxicity and the development of neuropathy.
    Krishnan AV; Goldstein D; Friedlander M; Kiernan MC
    Muscle Nerve; 2005 Jul; 32(1):51-60. PubMed ID: 15880395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered nerve excitability properties in established diabetic neuropathy.
    Krishnan AV; Kiernan MC
    Brain; 2005 May; 128(Pt 5):1178-87. PubMed ID: 15758031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.